Medication info
Rosuvastatin 2.5 mg (Rosuvastatin Calcium)

Rosuvastatin 2.5 mg (Rosuvastatin Calcium)

Prescription medicationTablet
Ingredient · strength
Rosuvastatin Calcium›2.6mg / 1 tablet
Manufacturer / importer
Samcheondang Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablets
Packaging
Domestic use - 30 tablets/bottle, Domestic use - 100 tablets/bottle
Approval status
Active

MFDS item code 202301248 · Approved 2023.04.14 · Insurance code 651205990

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who uses it
Adults
Adult dosage
Before and during treatment with this medicine, patients should follow a standard cholesterol-lowering diet and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 2.5 or 5 milligrams once daily. The dose may be adjusted to a maintenance dose if a greater reduction in LDL cholesterol is needed. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer, based on LDL cholesterol levels, treatment goals, and the patient's response; the dose may be increased to a maximum of 20 milligrams once daily. Elderly patients: No dose adjustment is needed. Patients with renal impairment: No dose adjustment is needed in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20 mg of this medicine to patients with moderate renal impairment. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or below, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 2.5 or 5 milligrams. The 40-milligram dose is contraindicated. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 2.5 or 5 milligrams. The 40-milligram dose is contraindicated in some of these patients.

Ingredients

Manufacturer
Samcheondang Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • mixed hyperlipidemia
View approved original text

This medication is used for primary hypercholesterolemia, especially heterozygous familial hypercholesterolemia, and mixed hyperlipidemia. It serves as an adjunct to dietary and exercise measures when control is difficult with diet alone. It helps in improving blood cholesterol levels and reducing the risk of cardiovascular diseases.

Dosage and Administration

Adult dosage

Before and during treatment with this medicine, patients should follow a standard cholesterol-lowering diet and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 2.5 or 5 milligrams once daily. The dose may be adjusted to a maintenance dose if a greater reduction in LDL cholesterol is needed. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer, based on LDL cholesterol levels, treatment goals, and the patient's response; the dose may be increased to a maximum of 20 milligrams once daily. Elderly patients: No dose adjustment is needed. Patients with renal impairment: No dose adjustment is needed in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20 mg of this medicine to patients with moderate renal impairment. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or below, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 2.5 or 5 milligrams. The 40-milligram dose is contraindicated. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 2.5 or 5 milligrams. The 40-milligram dose is contraindicated in some of these patients.

Precautions

This medication should not be used in certain patients. For example, it should not be administered to patients who are allergic to any of its components, have severely impaired liver function, have muscle disorders, are taking cyclosporine, or have very poor kidney function. Additionally, it should be avoided in pregnant or breastfeeding women, and women who may become pregnant and are not using appropriate contraception. This medication may have side effects related to muscle pain or muscle damage; therefore, patients with a history of muscle-related disorders, impaired kidney function, hypothyroidism, or those who consume alcohol excessively should use it with caution. Symptoms such as muscle pain, weakness, or cramps should be reported to a doctor immediately, and blood tests may be necessary to check for muscle damage. Liver function tests should be conducted regularly, and if symptoms of liver damage (fatigue, jaundice, loss of appetite, etc.) appear, the use of the medication should be stopped immediately. This medication may interact with other drugs, so it is essential to inform the doctor or pharmacist about any medications being taken. Particularly, the risk of muscle damage may increase when used with fibrate drugs or certain antibiotics, antifungals, and immunosuppressants. In pregnancy or breastfeeding, this medication may pose a risk to the fetus or baby, so it must be avoided. Women planning to become pregnant should use appropriate contraception. In case of overdose, there is no specific antidote, so one should visit a medical facility immediately for appropriate treatment and monitoring of liver function and muscle damage. While taking this medication, caution should be exercised as dizziness may occur when driving or operating machinery.

Side effects

dyspepsia, pruritus, immune thrombocytopenic purpura, facial swelling, herpes zoster, vulvar pruritus, angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, transaminase elevation, Stevens-Johnson syndrome, eosinophilia with systemic symptoms drug reaction syndrome, lichenoid drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, liver failure, cognitive impairment, ALT elevation, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distention, syncope, widespread pain, fatigue

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is also advised to store the medicine at a temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

White round film-coated tablets

Package unit

Domestic use - 30 tablets/bottle, Domestic use - 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.